HSC00189
/ Haisco
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Preclinical characterization of HSC00189, a novel bispecific ADC targeting cadherin-6 (CDH6) and folate receptor alpha (FOLR1) for the treatment of ovarian cancer
(AACR 2026)
- "Abstract is embargoed at this time."
ADC • Bispecific • Late-breaking abstract • Preclinical • Oncology • Ovarian Cancer • Solid Tumor • CDH6 • FOLR1
1 to 1
Of
1
Go to page
1